The Impact of the national shortage of polymyxin B in critically ill patients during the COVID-19 pandemic
DOI:
https://doi.org/10.17058/reci.v13i4.18403Keywords:
Polymyxin B, antimicrobials, Bacterial Antibiotic Resistance, aminoglycosides, COVID-19Abstract
Background and Objectives: during the COVID-19 pandemic, the number of critical patients requiring intensive care increased considerably, resulting in an increase in infections due to multi-resistant microorganisms. In Brazil, in 2021, due to the high demand for polymyxin B use, there was a national shortage of the medication. One strategy used to overcome this situation was aminoglycoside use. The work aimed to analyze the impact of replacing polymyxin B with amikacin and gentamicin in the final stage of patients. Method: an analytical study with an observational, cross-sectional design, with a quantitative approach, through a retrospective analysis through the analysis of medical records, with the primary stages being discharges or deaths. Results: mortality was similar between the group treated with aminoglycoside and the group treated with polymyxin B. Within the aminoglycoside group, mortality was higher in the group that had bacteria resistant to the drug than in the group that had infection with an organism sensitive to this drug. Mortality was not affected by comorbidities, age, or number of hospital infections. The main factor that led to the need for dialysis was the combination of two nephrotoxic medications. Conclusion: two hypotheses emerged: the first would be that replacing polymyxin B with aminoglycosides did not impact mortality; the other would be that, regardless of the antibiotic group used, patients had a high risk of death. Despite sample limitations, the study corroborates the adoption of strategies for the rational use of antimicrobials.
Downloads
References
Schrader SM, Vaubourgeix J, Nathan C. Biology of antimicrobial resistance and approaches to combat it. Science Translational Medicine 2020; 12(549). doi:10.1126/scitranslmed.aaz6992.
Mancuso, G, Midiri, A, Gerace, E, et al. Bacterial antibiotic resistance: The most critical pathogens. Pathogens 2021; 10(10):1310-2021. https://doi:org/10.3390/pathogens10101310.
Chokshi, A, Sifri, Z, Cennino, D, et al.Global contributors to antibiotic resistance. Journal of Global Infectious Diseases 2019, 11(1):1-36. doi:10.4103/jgid.jgid_110_18.
World Healf Organization New report calls for urgent action to avert antimicrobial resistance crisis, 2022. https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
Minante BI, Ticotosti GG, Barros IS, et al. Resistência antimicribiana pós- COVID-19: Revisão de Literatura. Revista Científica Multidisciplinar 2022; 3(3): 1-14. doi.org/10.47820/recima21.v3i3.1266.
V’kovski, P, Kratzel A, Steiner S., et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nature Reviews Microbiology 2021; 19:155–170. https://doi.org/10.1038/s41579-020-00468-6.
Huttner B, Catho G, Pano-Pardo JR, et al. COVID-19: don’t neglect antimicrobial stewardship principles! Clinical Microbiology and Infection 2020; 26:808–810. doi: 10.1016/j.cmi.2020.04.024.
Jornal O Globo. Pacientes que venceram a Covid-19 morrem por infecção hospitalar por desabastecimento de antibiótico, aponta levantamento 2022. https://g1.globo.com/jornal-hoje/noticia/2021/07/23/pacientes-que-venceram-a-covid-19-morrem-por-infeccao-hospitalar-por-desabastecimento-de-antibiotico-aponta-levantamento.ghtml.
Beirao EM, Consentino TB, Urtado P, et al. Avaliação impacto em microorganismos colonizantes após restrição de polimixina em UTI Hospital Terciário. The Brazilian Journal of Infectious Diseases 2022; EP 006. https://doi.org/10.1016/j.bjid.2021.101742.
Yusef D, Hayajneh WA, Bani Issa A, et al. Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter Baumannii (CRAb) in hospitals in Jordan. Journal of Antimicrobial Chemotherapy 2021; 76(2):516-523. https://doi.org/10.1093/jac/dkaa464.
Tuon FF, Yamada C, Telles J, et al. Doxiciclina oral para infecções por Acinetobacter Baumanni resistente a Carbapenem como uma estratégia de preservação de polimixina: resultados de uma corte retrospectiva. The Brazilian Journal of Infectious Diseases. 2022; 26(1): PI5. https://doi.org/10.1016/j.bjid.2021.10200.
Altunsoy A, Aypak C, Azap A, et al. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. International Journal of Medical Sciences 2011; 8(4):339-344. doi: 107150/ijms.8.339.
Curcio DJ. Antibiotic prescription in intensive care units in Latin America. Revista Argentina de Microbiología 2011; 43(3):203-211. doi:10.1590/S0325-75412011000300007.
de Souza Pinheiro LF, Martins CP, Martins CF, et al. Fatores de risco e mortalidade em pacientes criticamente enfermos com infecções por microrganismos multirresistentes. Revista Eletrônica Acervo Saúde 2021; 24;13(4):1:7. https://doi.org/10.25248/reas.e7319.2021.
Yamada, T, Fujii, S, Shigemi, A, et al. A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity. Journal of Infection and Chemotherapy 2021, 27(2):256-261. doi:10.1016/j.jiac.2020.09.033
Cataldo, R, Arancibia, M, Stojanocam J, et al. General concepts in biostatistics and clinical epidemiology: Observational studies with cross-sectional and ecological designs. Medwave 2019. v. 19, n. 8: 1-7. doi: 10.5867/medwave.2019.08.7698.
Rego A, Pina M, Meyer Jr V. Quantos participantes são necessários para um estudo qualitativo? Linhas práticas de orientação. Revista de Gestão dos Países de Língua Portuguesa 2018; 17(2):43-57. doi.org/10.12660/rgplp.v17n2.2018.78224.
Ballinger G A. Using generalized estimating equations for longitudinal data analysis. Organizational Research Methods 2004, 7(2):127–150. https://doi: 10.1177/1094428104263672.
Cui J, QIC Program and model selection in GEE analyses. The Stata Journal 2007, 7 (2):209–220, https://doi:10.1177/1536867X0700700205.
Mendes CAC, Burdmann EA. Polimixinas. Revisão com ênfase na sua nefrotoxicidade. Revista Associação Médica Brasil 2009; 55(6):752–758. doi.org/10.1590/S0104-42302009000600023.
Benito, LAO, Lima, RC, Karnikowski. MGO, Silva, ICR. Comorbidades e fatores de risco identificados em pessoas que vieram a óbito por Síndrome Respiratória Aguda Grave por Covid-19. Revista de Divulgação Científica Sena Aires 2021, 10(3): 607-623.
Rosa, RRPA; Lavareda, R, Linhares, JEBS. Influência das comorbidades para a ocorrência de óbitos por COVID-19 em 2020: razão de chances no estado do Amazonas. HU Revista 2022, 48:1-8.
Sousa-Munoz, RL, Ronconi, DE, Dantas, GC, Lucena, DMS. Impacto de multimorbidade sobre mortalidade em idosos: estudo de coorte pós-hospitalização. Revista Brasileira de Geriatria e Gerontologia 2013, 16:579-589.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fernanda Piazza Fernandes, Maria Cláudia Hahn Ferrucio
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author must state that the paper is original (has not been published previously), not infringing any copyright or other ownership right involving third parties. Once the paper is submitted, the Journal reserves the right to make normative changes, such as spelling and grammar, in order to maintain the language standard, but respecting the author’s style. The published papers become ownership of RECI, considering that all the opinions expressed by the authors are their responsibility. Because we are an open access journal, we allow free use of articles in educational and scientific applications provided the source is cited under the Creative Commons CC-BY license.
